Synthetic solutions for ethical and effective drug testing

FHS
July 22, 2024
7:05 pm

Improving human quality of life with drug treatments is a complicated issue. Drug certification, including drug safety and reliability, entails a long series of tests and government approvals before the drug is available for anyone to use.

Pα+: Knowledge Gaps in Psychedelic Medicalisation, According to ECNP and Regulators – Psychedelic Alpha

In a pre-proof of a forthcoming journal article, members of the European College of Neuropsychopharmacology (ECNP) including European Medicines Agency’s Chief Medical Officer, Steffen Thirstrup, discuss knowledge

January 17, 2024

Cybin Brings in Capital with Public Offering | Psychedelic Invest

On Monday, publicly-traded psychedelic company Cybin announced an overnight public offering, and its stock paid the price. This came as no surprise to anyone following

August 2, 2023

Assessing recurrence risk with ctDNA-based MRD detection in NSCLC patients

In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) has emerged as a promising approach to identify

November 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.